To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection
Clinical trial NCT04706468 · COMPLETED
Trial details
- NCT number
- NCT04706468
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-02-15
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.